<DOC>
	<DOCNO>NCT00557401</DOCNO>
	<brief_summary>To evaluate efficacy safety treatment XP19986 Sustained Release ( SR ) Tablet compare placebo subject symptomatic GERD</brief_summary>
	<brief_title>An Efficacy Safety Study XP19986 Subjects With Symptomatic GERD</brief_title>
	<detailed_description />
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Arbaclofen placarbil</mesh_term>
	<mesh_term>Baclofen</mesh_term>
	<criteria>History documentation GERD diagnose gastroenterologist , symptom ( heartburn and/or regurgitation ) â‰¥ 3 day week prior screen prior randomization Current historical endoscopic evidence erosive esophagitis LA Classification Grade B , C , D</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>